IBDEI2M1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,933,0)
 ;;=MENTAL HEALTH^25^84
 ;;^UTILITY(U,$J,358.4,934,0)
 ;;=MOVEMENT DISORDERS^26^84
 ;;^UTILITY(U,$J,358.4,935,0)
 ;;=MUSCULOSKELETAL^27^84
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=NEUROLOGY^28^84
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=PAIN^29^84
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=PREVENTIVE HEALTH^30^84
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=PULMONARY^31^84
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=SEXUAL TRAUMA^32^84
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^84
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^84
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=SUBSTANCE DISORDERS^35^84
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=VARICOSE VEINS^36^84
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=WOMEN'S HEALTH^37^84
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^84
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=COMA^7^84
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=CAUSES OF INJURY^6^84
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=DEMENTIA^8^84
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^84
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=NEW PATIENT^2^85
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=ESTABLISHED PATIENT^1^85
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=CONSULTATIONS^3^85
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=IMMUNIZATIONS^2^86
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=INJECTION^3^86
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=SKIN TESTS^10^86
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=NURSING PROCEDURES^5^86
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=MINOR PROCEDURES^4^86
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=SPLINTS^10^86
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^9^86
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^8^86
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=PREVENTIVE MED-EST PT^6^86
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=PREVENTIVE MED-NEW PT^7^86
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=IMMUNIZATION ADMIN^1^86
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=PC COMMON DIAGNOSES^1^87
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=ADMINISTRATIVE TOPICS^2^87
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=ANGINA^3^87
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=ATHEROSCLEROSIS^4^87
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=CARDIOVASCULAR^5^87
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=DERMATOLOGY^9^87
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=EAR DISORDERS^10^87
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=EENT^11^87
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=ENDOCRINE/METABOLIC^12^87
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=EYE DISORDERS^13^87
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=EYE INJURY^14^87
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=GASTROENTEROLOGY^15^87
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=GU/RENAL^16^87
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=HEADACHE^17^87
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=HEART FAILURE^18^87
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=HEART VALVE DISEASE^19^87
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^87
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=HISTORY OF ILLNESS^21^87
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=INFECTIOUS DISEASE^22^87
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=LIVER DISEASE^23^87
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=MENTAL HEALTH^25^87
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=MOVEMENT DISORDERS^26^87
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=MUSCULOSKELETAL^27^87
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=NEUROLOGY^28^87
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=PAIN^29^87
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=PREVENTIVE HEALTH^30^87
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=PULMONARY^31^87
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=SEXUAL TRAUMA^32^87
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^87
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^87
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=SUBSTANCE DISORDERS^35^87
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=VARICOSE VEINS^36^87
